Sagent Pharmaceuticals

^{, Nasdaq: SGNT}

Markets generic injectable drugs to the hospital market.

Industry: Health Care

First Day Return: +24.4%

SGNT

Markets generic injectable drugs to the hospital market.

IPO News for Sagent Pharmaceuticals

Sagent Pharmaceuticals quiet period ends May 30 05/25/11
Sagent Pharmaceuticals prices upsized IPO at $16, high end of the range 04/20/11
Sagent Pharmaceuticals reveals IPO terms 04/06/11

IPO Data
IPO Date	04/19/2011
Offer Price	IPO Intelligence Only
Price Range	IPO Intelligence Only
Offer Shares (mm)	IPO Intelligence Only
Deal Size ($mm)	$92
Lock-Up Date	IPO Intelligence Only
Street Research	IPO Intelligence Only

Underwriters
IPO Intelligence Only

Company Data
Website www.sagentpharma.com
Headquarters	Schaumburg, IL, United States
Founded	2006
Employees at IPO	84

IPO News for Sagent Pharmaceuticals

Sagent Pharmaceuticals quiet period ends May 30 05/25/11
Sagent Pharmaceuticals prices upsized IPO at $16, high end of the range 04/20/11
Sagent Pharmaceuticals reveals IPO terms 04/06/11

Sagent Pharmaceuticals (SGNT) Performance